Wang, Wenyu <br/><br/>
KDM6B Counteracts EZH2-Mediated Suppression of   [electronic resource] 

 -  Molecular cancer therapeutics  09 2018 
 - 1973-1983 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1538-8514 
<br/><br/><label>Standard No.: </label>10.1158/1535-7163.MCT-17-0802  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Breast Neoplasms--drug therapy<br/>Cell Line<br/>Cell Line, Tumor<br/>Cell Survival--drug effects<br/>Drug Resistance, Neoplasm--drug effects<br/>Enhancer of Zeste Homolog 2 Protein--genetics<br/>Epigenesis, Genetic<br/>Female<br/>Gene Expression Profiling--methods<br/>Gene Expression Regulation, Neoplastic--drug effects<br/>Humans<br/>Indazoles--pharmacology<br/>Insulin-Like Growth Factor Binding Protein 5--genetics<br/>Jumonji Domain-Containing Histone Demethylases--genetics<br/>Kaplan-Meier Estimate<br/>MCF-7 Cells<br/>Phosphatidylinositol 3-Kinases--genetics<br/>Phosphoinositide-3 Kinase Inhibitors<br/>Proto-Oncogene Proteins c-akt--antagonists & inhibitors<br/>Sulfonamides--pharmacology